Hussman Strategic Advisors’s Dynavax Technologies DVAX Stock Holding History

Hussman Strategic Advisors’s Portfolio DVAX Stock Details DVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-84,000	Closed	-$943K	–	251
2024 Q2	$943K	Hold	84,000	–	–	0.26%	146
2024 Q1	$1.04M	Hold	84,000	–	–	0.24%	146
2023 Q4	$1.17M	Sell	84,000 -40,000	-32%	-$556K	0.27%	145
2023 Q3	$1.83M	Hold	124,000	–	–	0.35%	120
2023 Q2	$1.6M	Hold	124,000	–	–	0.29%	154
2023 Q1	$1.22M	Buy	124,000 +46,500	+60%	+$496K	0.19%	200
2022 Q4	$825K	Hold	77,500	–	–	0.13%	223
2022 Q3	$809K	Buy	+77,500	New	+$1.01M	0.14%	226
2018 Q3	–	Sell	-75,000	Closed	-$1.14M	–	228
2018 Q2	$1.14M	Hold	75,000	–	–	0.31%	126
2018 Q1	$1.49M	Buy	+75,000	New	+$1.3M	0.41%	105

Other funds holding DVAX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Hussman Strategic Advisors's DVAX Position: Q3 2024 in Review

Hussman Strategic Advisors sold out of Dynavax Technologies (DVAX) in Q3 2024, closing a stake of 84,000 shares — an estimated $943K sold.

Hussman Strategic Advisors first reported a position in DVAX in Q1 2018 and held it in 10 quarters. The position peaked at $1.83M in Q3 2023. 251 funds tracked by Wall St. Rank hold DVAX as of Q3 2024.

Hussman Strategic Advisors reported no remaining Dynavax Technologies position as of Q3 2024 after selling out during the quarter.
Hussman Strategic Advisors sold 84,000 Dynavax Technologies shares in Q3 2024, an estimated $943K.
Hussman Strategic Advisors first reported a position in Dynavax Technologies in Q1 2018 and held it in 10 quarters.
Hussman Strategic Advisors's Dynavax Technologies position peaked at $1.83M in Q3 2023.
251 funds tracked by Wall St. Rank held Dynavax Technologies as of Q3 2024.

Based on Hussman Strategic Advisors's 13F filing for Q3 2024, filed 1 Nov 2024.